| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/23/2004 | EP1430045A1 Pyrane derivatives as both ace- and nep-inhibitors |
| 06/23/2004 | EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 06/23/2004 | EP1169470B1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
| 06/23/2004 | CN1507356A Remedies for sepsis |
| 06/23/2004 | CN1154656C Memory-improving peptides and their application |
| 06/23/2004 | CN1154655C K receptor opioid peptides |
| 06/23/2004 | CN1154654C Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3- phenylpropyl)-L-alanyl-L-proline |
| 06/23/2004 | CN1154653C Peptide and method of obtaining it |
| 06/22/2004 | US6753431 Production of mixed acid anhydride and amide compound |
| 06/22/2004 | US6753410 Investigational compounds |
| 06/22/2004 | US6753409 For treatment of myocardial infarction, stroke, peripheral arterial disease and disseminated intravascular coagulation |
| 06/22/2004 | US6753317 Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use |
| 06/22/2004 | US6753310 Neovascular-specific peptides |
| 06/22/2004 | CA2276107C Improved substrates for human cytomegalovirus protease |
| 06/17/2004 | WO2004050851A2 Prion protein ligands and methods of use |
| 06/17/2004 | WO2004050689A2 Aza-peptides |
| 06/17/2004 | WO2004050620A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 06/17/2004 | WO2004050084A2 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
| 06/17/2004 | US20040116699 Melanocortin receptor agonists |
| 06/17/2004 | US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
| 06/17/2004 | US20040116656 Memory-enhancing peptides and the use thereof |
| 06/17/2004 | US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | CA2836951A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2507936A1 Prion protein ligands and methods of use |
| 06/17/2004 | CA2505150A1 Aza-peptides |
| 06/16/2004 | EP1428533A2 Use of thiazolidine- or pyrrolidine-derivatives of aminoacids as antihyperglycemic agents |
| 06/16/2004 | EP1428530A1 Tetrapeptide derivative crystals |
| 06/16/2004 | EP1427758A2 Compositions and methods of treating diabetes |
| 06/16/2004 | EP1427405A2 Inflammation-inhibiting compounds |
| 06/16/2004 | EP1246839B1 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/16/2004 | EP1075797B1 Novel sweetener compositions |
| 06/16/2004 | CN1505617A Peptides as met-ap2 inhibitors |
| 06/16/2004 | CN1504480A Endothelin receptor antagonist of tripeptide |
| 06/16/2004 | CN1504479A Bone formation stimulant, synthetic method and uses thereof |
| 06/16/2004 | CN1504462A Pyrimidinyl derivatives as interleukin inhibitors |
| 06/16/2004 | CN1504235A Tie2 receptor-induced gene transfer system for treating target tumor genes |
| 06/15/2004 | US6750209 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/15/2004 | CA2109256C Technetium or rhenium-binding bi-hapten derivatives, a process for their preparation, diagnostic and therapeutic application, and kits and immunological reagents containing same |
| 06/10/2004 | WO2004048400A1 Peptide gap junction modulators |
| 06/10/2004 | WO2004047772A2 Catalytic antioxidants and methods of use |
| 06/10/2004 | WO2004047762A2 Methods for treating cancer using porimin as a target |
| 06/10/2004 | US20040110929 compounds that bind to and inhibit the activity of tissue factor (TF) and mediate a cytolytic immune response; used in treatment of or prophylaxis of diseases or disorders related to pathophysiological TF activity including cancer, inflammation etc |
| 06/10/2004 | US20040110806 Dipeptide derivatives |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | CA2507215A1 Methods for treating cancer using porimin as a target |
| 06/10/2004 | CA2506490A1 Peptide gap junction modulators |
| 06/09/2004 | EP1426062A2 Radiolabeled annexins |
| 06/09/2004 | EP1425029A1 Peptidomimetics of biologically active metallopeptides |
| 06/09/2004 | EP1425009A2 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 06/09/2004 | EP1246824B1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 06/09/2004 | EP1019364B1 Inhibitors of protein tyrosine phosphatase |
| 06/09/2004 | EP0956294B1 Thrombin inhibitors |
| 06/09/2004 | CN1503780A Process for producing N-formylamino acid and utilization thereof |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/08/2004 | US6747157 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 06/08/2004 | US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication |
| 06/08/2004 | US6747127 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators |
| 06/08/2004 | US6747060 Non-natural galanin receptor ligands |
| 06/08/2004 | US6747009 Peptidomimetic glutathione analogs |
| 06/03/2004 | WO2004046173A1 Scaffolds useful to the synthesis of compounds with biological activity |
| 06/03/2004 | WO2004046172A1 Perindopril |
| 06/03/2004 | WO2004046171A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004046170A2 Tubulysins, method for producing the same and tubulysin preparations |
| 06/03/2004 | WO2004046089A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2003015706A3 Borinic acid protease inhibitors |
| 06/03/2004 | US20040106820 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106598 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/03/2004 | US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | US20040106552 amyloid precursor proteins; for use in treatment of Alzheimer's disease/neurodegenerative diseases and as cognitive enhancers |
| 06/03/2004 | US20040106154 In vivo screen using chemical inducers of dimerization |
| 06/03/2004 | US20040105928 Sweetener compositions and uses thereof |
| 06/03/2004 | DE10254439A1 Tubulysine, Herstellungsverfahren und Tubulysin-Mittel Tubulysins, manufacturing methods and means tubulysin |
| 06/03/2004 | CA2506587A1 A process to prepare a pharmaceutically acceptable salt of perindopril |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423411A2 Prodrugs of excitatory amino acids |
| 06/02/2004 | EP1423410A2 Peptides having a c-terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i |
| 06/02/2004 | EP1423373A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 06/02/2004 | EP1423135A2 Methods for inhibiting angiogenesis |
| 06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
| 06/02/2004 | EP0948344A4 Synthetic antibiotics |
| 06/02/2004 | CN1501942A Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1500804A Preparing method for thread group cyclic dipeptide |
| 06/02/2004 | CN1500784A New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts ofranelic acid and thei |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1152049C Treatment of insulin resistance with growth hormone secretagogues |
| 06/02/2004 | CN1152048C Perfluoroalkyl ketone inhibitors of elastase and preparing method thereof |
| 06/02/2004 | CN1152039C Benzo (b) thiepine-1, 1-dioxide derivatives, producing method thereof, combination containing the same and uses thereof |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 05/27/2004 | WO2004044000A2 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | WO2004043993A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 05/27/2004 | WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors |
| 05/27/2004 | WO2004043482A1 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser |